Adverse events: race, inequality, and the testing of new pharmaceuticals
""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"--
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
New York University Press
[2020]
|
| Schlagworte: | |
| Zusammenfassung: | ""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"-- |
| Beschreibung: | vii, 319 Seiten Diagramme 23 cm |
| ISBN: | 9781479877997 9781479862160 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV046847330 | ||
| 003 | DE-604 | ||
| 005 | 20210121 | ||
| 007 | t | ||
| 008 | 200810s2020 |||| |||| 00||| eng d | ||
| 020 | |a 9781479877997 |c (cloth) |9 978-1-47987799-7 | ||
| 020 | |a 9781479862160 |c (paperback) |9 978-1-47986216-0 | ||
| 035 | |a (OCoLC)1191904180 | ||
| 035 | |a (DE-599)BVBBV046847330 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-188 |a DE-11 | ||
| 082 | 0 | |a 615.10973 |2 23 | |
| 084 | |a MS 6220 |0 (DE-625)123745: |2 rvk | ||
| 084 | |a MS 3530 |0 (DE-625)123683: |2 rvk | ||
| 084 | |a MS 1300 |0 (DE-625)123591: |2 rvk | ||
| 100 | 1 | |a Fisher, Jill A. |d 1976- |e Verfasser |0 (DE-588)13708434X |4 aut | |
| 245 | 1 | 0 | |a Adverse events |b race, inequality, and the testing of new pharmaceuticals |c Jill A. Fisher |
| 264 | 1 | |a New York |b New York University Press |c [2020] | |
| 264 | 4 | |c © 2020 | |
| 300 | |a vii, 319 Seiten |b Diagramme |c 23 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 505 | 8 | |a Introduction: "Your health is your wealth" -- Entering the clinic -- "Doing the lab rat thing" -- A tale of three cultures -- The commercialization of phase I trials -- A laboratory for human animals -- The dark side of the model -- Consenting to study adverse events -- Constructing risk knowledge -- Speculating on health -- Conclusion: The social inequality of adverse events | |
| 520 | |a ""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"-- | ||
| 650 | 4 | |a Drugs / Testing / Social aspects / United States | |
| 650 | 4 | |a Human experimentation in medicine / Moral and ethical aspects / United States | |
| 650 | 4 | |a Racism in medicine / United States | |
| 650 | 4 | |a Equality / Health aspects / United States | |
| 650 | 4 | |a Clinical Trials as Topic / ethics | |
| 650 | 4 | |a Human Experimentation / ethics | |
| 650 | 4 | |a Racism | |
| 650 | 4 | |a Civil Rights | |
| 650 | 7 | |a Drugs / Testing / Social aspects |2 fast | |
| 650 | 7 | |a Equality / Health aspects |2 fast | |
| 650 | 7 | |a Human experimentation in medicine / Moral and ethical aspects |2 fast | |
| 650 | 7 | |a Racism in medicine |2 fast | |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Menschenversuch |0 (DE-588)4038649-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Soziale Ungleichheit |0 (DE-588)4055736-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Egalitarismus |0 (DE-588)4151082-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Klinische Prüfung |0 (DE-588)4031192-2 |2 gnd |9 rswk-swf |
| 651 | 4 | |a United States | |
| 651 | 7 | |a United States |2 fast | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 0 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 2 | |a Arzneimittelprüfung |0 (DE-588)4128030-1 |D s |
| 689 | 0 | 3 | |a Egalitarismus |0 (DE-588)4151082-3 |D s |
| 689 | 0 | 4 | |a Klinische Prüfung |0 (DE-588)4031192-2 |D s |
| 689 | 0 | 5 | |a Menschenversuch |0 (DE-588)4038649-1 |D s |
| 689 | 0 | 6 | |a Soziale Ungleichheit |0 (DE-588)4055736-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-47986143-9 |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-47985051-8 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032256217 | ||
Datensatz im Suchindex
| _version_ | 1804181678070956032 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Fisher, Jill A. 1976- |
| author_GND | (DE-588)13708434X |
| author_facet | Fisher, Jill A. 1976- |
| author_role | aut |
| author_sort | Fisher, Jill A. 1976- |
| author_variant | j a f ja jaf |
| building | Verbundindex |
| bvnumber | BV046847330 |
| classification_rvk | MS 6220 MS 3530 MS 1300 |
| contents | Introduction: "Your health is your wealth" -- Entering the clinic -- "Doing the lab rat thing" -- A tale of three cultures -- The commercialization of phase I trials -- A laboratory for human animals -- The dark side of the model -- Consenting to study adverse events -- Constructing risk knowledge -- Speculating on health -- Conclusion: The social inequality of adverse events |
| ctrlnum | (OCoLC)1191904180 (DE-599)BVBBV046847330 |
| dewey-full | 615.10973 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.10973 |
| dewey-search | 615.10973 |
| dewey-sort | 3615.10973 |
| dewey-tens | 610 - Medicine and health |
| discipline | Soziologie Medizin |
| discipline_str_mv | Soziologie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03291nam a2200721 c 4500</leader><controlfield tag="001">BV046847330</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210121 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">200810s2020 |||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781479877997</subfield><subfield code="c">(cloth)</subfield><subfield code="9">978-1-47987799-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781479862160</subfield><subfield code="c">(paperback)</subfield><subfield code="9">978-1-47986216-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1191904180</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046847330</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.10973</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6220</subfield><subfield code="0">(DE-625)123745:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 3530</subfield><subfield code="0">(DE-625)123683:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 1300</subfield><subfield code="0">(DE-625)123591:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fisher, Jill A.</subfield><subfield code="d">1976-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)13708434X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adverse events</subfield><subfield code="b">race, inequality, and the testing of new pharmaceuticals</subfield><subfield code="c">Jill A. Fisher</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">New York University Press</subfield><subfield code="c">[2020]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">vii, 319 Seiten</subfield><subfield code="b">Diagramme</subfield><subfield code="c">23 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Introduction: "Your health is your wealth" -- Entering the clinic -- "Doing the lab rat thing" -- A tale of three cultures -- The commercialization of phase I trials -- A laboratory for human animals -- The dark side of the model -- Consenting to study adverse events -- Constructing risk knowledge -- Speculating on health -- Conclusion: The social inequality of adverse events</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"--</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Testing / Social aspects / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human experimentation in medicine / Moral and ethical aspects / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Racism in medicine / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Equality / Health aspects / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clinical Trials as Topic / ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human Experimentation / ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Racism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Civil Rights</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Testing / Social aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Equality / Health aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Human experimentation in medicine / Moral and ethical aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Racism in medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Menschenversuch</subfield><subfield code="0">(DE-588)4038649-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Soziale Ungleichheit</subfield><subfield code="0">(DE-588)4055736-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Egalitarismus</subfield><subfield code="0">(DE-588)4151082-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinische Prüfung</subfield><subfield code="0">(DE-588)4031192-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">United States</subfield><subfield code="2">fast</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelprüfung</subfield><subfield code="0">(DE-588)4128030-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Egalitarismus</subfield><subfield code="0">(DE-588)4151082-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Klinische Prüfung</subfield><subfield code="0">(DE-588)4031192-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="5"><subfield code="a">Menschenversuch</subfield><subfield code="0">(DE-588)4038649-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="6"><subfield code="a">Soziale Ungleichheit</subfield><subfield code="0">(DE-588)4055736-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-47986143-9</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-47985051-8</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032256217</subfield></datafield></record></collection> |
| geographic | United States United States fast USA (DE-588)4078704-7 gnd |
| geographic_facet | United States USA |
| id | DE-604.BV046847330 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T15:08:51Z |
| indexdate | 2024-07-10T08:55:28Z |
| institution | BVB |
| isbn | 9781479877997 9781479862160 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032256217 |
| oclc_num | 1191904180 |
| open_access_boolean | |
| owner | DE-188 DE-11 |
| owner_facet | DE-188 DE-11 |
| physical | vii, 319 Seiten Diagramme 23 cm |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | New York University Press |
| record_format | marc |
| spelling | Fisher, Jill A. 1976- Verfasser (DE-588)13708434X aut Adverse events race, inequality, and the testing of new pharmaceuticals Jill A. Fisher New York New York University Press [2020] © 2020 vii, 319 Seiten Diagramme 23 cm txt rdacontent n rdamedia nc rdacarrier Introduction: "Your health is your wealth" -- Entering the clinic -- "Doing the lab rat thing" -- A tale of three cultures -- The commercialization of phase I trials -- A laboratory for human animals -- The dark side of the model -- Consenting to study adverse events -- Constructing risk knowledge -- Speculating on health -- Conclusion: The social inequality of adverse events ""Adverse Events" explores the connections between race, inequality, and the testing of new pharmaceuticals"-- Drugs / Testing / Social aspects / United States Human experimentation in medicine / Moral and ethical aspects / United States Racism in medicine / United States Equality / Health aspects / United States Clinical Trials as Topic / ethics Human Experimentation / ethics Racism Civil Rights Drugs / Testing / Social aspects fast Equality / Health aspects fast Human experimentation in medicine / Moral and ethical aspects fast Racism in medicine fast Arzneimittel (DE-588)4003115-9 gnd rswk-swf Menschenversuch (DE-588)4038649-1 gnd rswk-swf Soziale Ungleichheit (DE-588)4055736-4 gnd rswk-swf Egalitarismus (DE-588)4151082-3 gnd rswk-swf Arzneimittelprüfung (DE-588)4128030-1 gnd rswk-swf Klinische Prüfung (DE-588)4031192-2 gnd rswk-swf United States United States fast USA (DE-588)4078704-7 gnd rswk-swf USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Arzneimittelprüfung (DE-588)4128030-1 s Egalitarismus (DE-588)4151082-3 s Klinische Prüfung (DE-588)4031192-2 s Menschenversuch (DE-588)4038649-1 s Soziale Ungleichheit (DE-588)4055736-4 s DE-604 Erscheint auch als Online-Ausgabe 978-1-47986143-9 Erscheint auch als Online-Ausgabe 978-1-47985051-8 |
| spellingShingle | Fisher, Jill A. 1976- Adverse events race, inequality, and the testing of new pharmaceuticals Introduction: "Your health is your wealth" -- Entering the clinic -- "Doing the lab rat thing" -- A tale of three cultures -- The commercialization of phase I trials -- A laboratory for human animals -- The dark side of the model -- Consenting to study adverse events -- Constructing risk knowledge -- Speculating on health -- Conclusion: The social inequality of adverse events Drugs / Testing / Social aspects / United States Human experimentation in medicine / Moral and ethical aspects / United States Racism in medicine / United States Equality / Health aspects / United States Clinical Trials as Topic / ethics Human Experimentation / ethics Racism Civil Rights Drugs / Testing / Social aspects fast Equality / Health aspects fast Human experimentation in medicine / Moral and ethical aspects fast Racism in medicine fast Arzneimittel (DE-588)4003115-9 gnd Menschenversuch (DE-588)4038649-1 gnd Soziale Ungleichheit (DE-588)4055736-4 gnd Egalitarismus (DE-588)4151082-3 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd Klinische Prüfung (DE-588)4031192-2 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4038649-1 (DE-588)4055736-4 (DE-588)4151082-3 (DE-588)4128030-1 (DE-588)4031192-2 (DE-588)4078704-7 |
| title | Adverse events race, inequality, and the testing of new pharmaceuticals |
| title_auth | Adverse events race, inequality, and the testing of new pharmaceuticals |
| title_exact_search | Adverse events race, inequality, and the testing of new pharmaceuticals |
| title_exact_search_txtP | Adverse events race, inequality, and the testing of new pharmaceuticals |
| title_full | Adverse events race, inequality, and the testing of new pharmaceuticals Jill A. Fisher |
| title_fullStr | Adverse events race, inequality, and the testing of new pharmaceuticals Jill A. Fisher |
| title_full_unstemmed | Adverse events race, inequality, and the testing of new pharmaceuticals Jill A. Fisher |
| title_short | Adverse events |
| title_sort | adverse events race inequality and the testing of new pharmaceuticals |
| title_sub | race, inequality, and the testing of new pharmaceuticals |
| topic | Drugs / Testing / Social aspects / United States Human experimentation in medicine / Moral and ethical aspects / United States Racism in medicine / United States Equality / Health aspects / United States Clinical Trials as Topic / ethics Human Experimentation / ethics Racism Civil Rights Drugs / Testing / Social aspects fast Equality / Health aspects fast Human experimentation in medicine / Moral and ethical aspects fast Racism in medicine fast Arzneimittel (DE-588)4003115-9 gnd Menschenversuch (DE-588)4038649-1 gnd Soziale Ungleichheit (DE-588)4055736-4 gnd Egalitarismus (DE-588)4151082-3 gnd Arzneimittelprüfung (DE-588)4128030-1 gnd Klinische Prüfung (DE-588)4031192-2 gnd |
| topic_facet | Drugs / Testing / Social aspects / United States Human experimentation in medicine / Moral and ethical aspects / United States Racism in medicine / United States Equality / Health aspects / United States Clinical Trials as Topic / ethics Human Experimentation / ethics Racism Civil Rights Drugs / Testing / Social aspects Equality / Health aspects Human experimentation in medicine / Moral and ethical aspects Racism in medicine Arzneimittel Menschenversuch Soziale Ungleichheit Egalitarismus Arzneimittelprüfung Klinische Prüfung United States USA |
| work_keys_str_mv | AT fisherjilla adverseeventsraceinequalityandthetestingofnewpharmaceuticals |